Genocopy of EVI1 ‐ AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking
British Journal of Haematology · 2026
DOI: 10.1111/bjh.19922 ↗Kurz gefasst
Fallbericht in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Julian List und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Faculty of Medicine, Freiburg, Germany. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Leukemia, Myeloid, Acute, MDS1 and EVI1 Complex Locus Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: IMMediate Advanced Clinician Scientist-Program, Else-Kröner-Fresenius-Stiftung.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes insipidus (DI) in patients with acute myeloid leukaemia (AML) and chromosome 3q alterations ( EVI1/PRDM3/MECOM overexpression) constitutes a poorly understood paraneoplasia. A 44‐year‐old patient presented with clinical and morphological features of this syndrome but, surprisingly, disclosed the rare translocation t(1;2)(p36;p21), with massive PRDM16 overexpression. WGS and RNA sequencing suggest enhancer hijacking of the ZFP36L2 enhancer region as underlying mechanism. Methylome alterations were similar to those in EVI1/PRDM3/MECOM AML, indicating converging pathways. The patient was successfully allografted, she is in complete remission 14 months later. We conclude that t(1;2)(p36;p21), with massive PRDM16 overexpression, can result in a faithful genocopy of EVI1/PRDM3/MECOM AML, including DI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Faculty of Medicine, Freiburg, Germany.
- Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Oncology Department, St. Claraspital, Basel, Switzerland.
ORCID-Profile: Julian List, Michael Lübbert
Förderung
- IMMediate Advanced Clinician Scientist-Program
- Else-Kröner-Fresenius-Stiftung
Zitieren
APA
List, J., Sollier, E., Brown-Burke, F., Kelly, K., Pfeifer, D., Shlyakhto, V., Maas-Bauer, K., Pantic, M., Plass, C., & Lübbert, M. (2026). Genocopy of EVI1 ‐ AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking. British Journal of Haematology. https://doi.org/10.1111/bjh.19922
Vancouver
List J, Sollier E, Brown-Burke F, Kelly K, Pfeifer D, Shlyakhto V, et al. Genocopy of EVI1 ‐ AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking. British Journal of Haematology. 2026. doi:10.1111/bjh.19922
BibTeX
@article{List2026,
author = {List, Julian and Sollier, Etienne and Brown-Burke, Fiona and Kelly, Katherine and Pfeifer, Dietmar and Shlyakhto, Valeria and Maas-Bauer, Kristina and Pantic, Milena and Plass, Christoph and Lübbert, Michael},
title = {Genocopy of EVI1 ‐ AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.19922}
}
EUVIMED